Jessica Gutiérrez-Nájera, Víctor Manuel Mendoza-Núñez
{"title":"Effect of Probiotic Supplementation on Body Fat, Skeletal Muscle Mass, and Body Mass Index in Individuals ≥45 Years Old: A Systematic Review.","authors":"Jessica Gutiérrez-Nájera, Víctor Manuel Mendoza-Núñez","doi":"10.21873/invivo.13927","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Probiotics are living microorganisms that confer health benefits when administered in adequate amounts. Several studies have shown the positive effects on body fat, muscle mass, and body mass index (BMI) in young adults and athletes; however, the results in adults aged ≥45 years are not conclusive.</p><p><strong>Materials and methods: </strong>A systematic review was conducted in accordance with the PRISMA guidelines, analyzing studies up to December 10, 2024, from nine databases (PubMed, Scopus, Web of Science, LILACS, SciELO, Springer, Redalyc, Cochrane Library and TESIUNAM). Mean differences (MD) were estimated using RevMan V 5.4.1. software.</p><p><strong>Results: </strong>Six hundred and sixty-six studies were identified, of which 15 met the eligibility criteria. A statistically significant decrease in fat mass (%) was found in two studies and in fat mass (kg) in another two studies. Likewise, one study reported a statistically significant increase in skeletal muscle mass.</p><p><strong>Conclusion: </strong>Probiotic supplementation may have a beneficial effect on reducing body fat mass and increasing or preventing skeletal muscle mass loss in adults ≥45 years old; however, further clinical trials are needed to determine the optimal types, doses, and duration of probiotic treatment for best results.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 3","pages":"1220-1236"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041995/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.13927","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background/aim: Probiotics are living microorganisms that confer health benefits when administered in adequate amounts. Several studies have shown the positive effects on body fat, muscle mass, and body mass index (BMI) in young adults and athletes; however, the results in adults aged ≥45 years are not conclusive.
Materials and methods: A systematic review was conducted in accordance with the PRISMA guidelines, analyzing studies up to December 10, 2024, from nine databases (PubMed, Scopus, Web of Science, LILACS, SciELO, Springer, Redalyc, Cochrane Library and TESIUNAM). Mean differences (MD) were estimated using RevMan V 5.4.1. software.
Results: Six hundred and sixty-six studies were identified, of which 15 met the eligibility criteria. A statistically significant decrease in fat mass (%) was found in two studies and in fat mass (kg) in another two studies. Likewise, one study reported a statistically significant increase in skeletal muscle mass.
Conclusion: Probiotic supplementation may have a beneficial effect on reducing body fat mass and increasing or preventing skeletal muscle mass loss in adults ≥45 years old; however, further clinical trials are needed to determine the optimal types, doses, and duration of probiotic treatment for best results.
背景/目的:益生菌是一种活的微生物,当给予足够的量时,可以带来健康益处。几项研究表明,对年轻人和运动员的身体脂肪、肌肉质量和身体质量指数(BMI)有积极影响;然而,年龄≥45岁的成年人的结果并不是决定性的。材料和方法:根据PRISMA指南进行系统评价,分析截至2024年12月10日的9个数据库(PubMed、Scopus、Web of Science、LILACS、SciELO、施普林格、Redalyc、Cochrane Library和TESIUNAM)的研究。使用RevMan V 5.4.1估计平均差异(MD)。软件。结果:共纳入666项研究,其中15项符合入选标准。两项研究发现脂肪质量(%)和另外两项研究发现脂肪质量(kg)在统计学上显著降低。同样,一项研究报告了骨骼肌质量的统计学显著增加。结论:在≥45岁的成年人中,补充益生菌可能具有减少体脂量和增加或防止骨骼肌质量损失的有益作用;然而,需要进一步的临床试验来确定益生菌治疗的最佳类型、剂量和持续时间,以获得最佳效果。
期刊介绍:
IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.
The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.